Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Spectral Medical Inc T.EDT

Alternate Symbol(s):  EDTXF

Spectral Medical Inc. is a Canada-based late-stage theragnostic company advancing therapeutic options for sepsis and septic shock. The Company develops and commercializes a treatment for septic shock utilizing its Endotoxin Activity Assay (EAA) diagnostic and the Toraymyxin therapeutic (PMX). PMX is a therapeutic hemoperfusion device that removes endotoxin, which can cause sepsis, from the bloodstream and is guided by the Company’s EAA. PMX is approved for therapeutic use in Japan and Europe and has been used safely and effectively on more than 340,000 patients to date. It has pioneered the development of biochemical markers for the clinical syndrome known as septic shock. It is continuing its legacy business of manufacturing and selling certain proprietary reagents. It develops, produces and markets recombinant proteins, antibodies and calibrators. These materials are sold for use in research and development, as well as in products manufactured by other diagnostic companies.


TSX:EDT - Post by User

Comment by BayStreetWildon Mar 02, 2023 7:48pm
82 Views
Post# 35316443

RE:RE:RE:RE:Hospitals don’t want to do trials anymore..

RE:RE:RE:RE:Hospitals don’t want to do trials anymore..

What facts do you need?


50 million dollars, 3-4 years, and 52 patients to show for it. 

800k a year in total ceo compensation. He's getting paid like he's running a major corporation and has the financial results of a local lemonade stand. 

You can go on glassdoor.com and look at what every person working for the company has said. (It's not pretty)

They consistently over promise and underdeliver. Most if not all investors think it's done intentionally.

Revenue is going down YOY

Lost control of Dialco

Mass departures from top management and best talent

Failed deadlines

Amory didn't stick around for more than a few months. Saw the writing on the wall reallllllyy quick. 

But pump on.
 

<< Previous
Bullboard Posts
Next >>